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KEY NOTES
 We have tested three candidate SNPs to measure any association with birth condition.
 There was evidence that one (rs1835740) was associated with the need for resuscitation and Apgar scores, with a substantial population impact.
 This is some of the first in vivo evidence implicating glutamate in perinatal asphyxia.
INTRODUCTION
Most infants tolerate the birth process well, but ~7% require some degree of resuscitation and ~0.5% of all births go on to develop immediate signs of brain damage.(1) We(1) and others (3) have been attempting to quantify the effect and wider impact of physiological compromise during the birth process. It is well recognized that infants born in poor condition, and in particular those who go on to develop signs of neurological impairment shortly after birth, have increased risk of movement disorders (cerebral palsy) and intellectual disability.(4) The outcomes is also devastating for the patients' family and society. (5, 6) We have shown that the neurological impairment persist through childhood(1) into adulthood.(2) Our work has also suggested important effects on social measures of outcome such as income, education and marriage.(7) Importantly, we have reported long-term impacts in infants who only required brief life support at birth and had no noticeable problems in the neonatal period, (1, 7) consistent with the hypothesis of a "Continuum of Reproductive Casualty." (8) Hypoxic events are frequently associated with birth complications.(9) It has been proposed that the major excitatory neurotransmitter glutamate and its receptors play a key role in the neural damage that occurs during hypoxic episodes in the developing brain (10) . Indeed, glutamate concentration has been found to be markedly increased in the cerebrospinal fluid (11) and also in the basal ganglia of asphyxiated newborn infants measured in vivo by Magnetic Resonance Spectroscopy. (12) While in vivo evidence is limited, single nucleotide polymorphisms (SNPs) affecting gene transciption and protein function in glutamatergic signalling and cell survival pathways may play a key role in cerebral recovery after hypoxic events. (13) In acute ischaemic brain injury in newborns, the primary step leading to excitotoxicity and neuronal death is the excessive activation of glutamate receptors, principally the synaptic and GluN2B subunit-containing extrasynaptic N-methyl-D-asparate receptors (NMDARs). (13, 14) GluN2B is highly expressed during the perinatal developmental period and deletions in the GluN2B gene are associated with cognitive disability in children. (15) Intriguingly, the functional polymorphism rs2284411 in GluN2R has an impact on susceptibility to neurodevelopmental disorders in children. (16) The serine/threonine kinase Akt (or protein kinase B, PKB) mediates neuronal cell survival in response to growth factors in the developing central nervous system(17) and involved in group I metabotropic glutamate receptor-linked signalling.(18) Akt has been reported to enhance cell survival in neurones by blocking induction of apoptosis. (19) The SNP rs2498804 in the Akt gene have been found to impair Akt function resulting in increased apoptosis. (21) In patients with schizophrenia who were born after obstetric complications this variant was more common, suggesting that this SNP may increase foetal vulnerability to hypoxia. (20) SNP rs1835740, is located between astrocyte elevated gene 1 (AEG1) (21) and plasma glutamate carboxypeptidase (PGCP). (22) AEG1 down regulates the major glutamate transporter, the excitatory amino-acid transporter-2 (EAAT2), in the central nervous system (CNS) and PGCP is involved in glutamate synthesis. rs1835740 was demonstrated to be a cis-acting regulator of AEG-1 and the risk A allele (in forward orientation T allele) was associated with higher expression levels of AEG1 and the development of migraine (22) and cluster headaches, suggesting a link between the rs1835740 variant and impaired regulation of glutamate levels in the CNS. (20, 21) We hypothesise that these functional SNPs affecting glutamatergic signalling, homeostasis and cell survival in the CNS may influence infants' susceptibility to the birth process and subsequent development of neurological impairment. Identification of a SNP related to birth condition could provide both insight into presumed pathophysiological pathways, as well as a marker to assess the true impact of perinatal asphyxia at a population level.
This study is drawn from the Avon Longitudinal Study of Parents and Children (ALSPAC), an ongoing study containing data on over 14,000 infants (23) 
Gene Data
Exposure measures were the presence of one or more minor alleles in one of three SNPs (rs2284411, rs2498804, rs1835740; Table 1 ) proposed to modify the association between hypoxic stress and neuronal injury.
Outcome measures
The primary outcome, consistent with our previous work in poor condition at birth, (1) . (1) The demographics of the infants included in the study are described in Table 2 .
Statistical Methods
To assess the association between the individual SNP genotypes and the three outcomes, univariable comparisons were performed for each genotype. Logistic or ordinal regression models (as appropriate) were then derived to assess the association of each increasing minor-allele with the three outcomes. Population attributable risks were calculated from the final logistic regression model.
Four sensitivity analyses were performed to investigate alternative mechanisms for any SNP association (e.g. effects on gestational age at birth). In the first the association between the three SNPs and resuscitation was adjusted for antenatal (gender, parity, maternal hypertension) and then intrapartum factors (gestational age, birth weight, length and head circumference, mode of birth and neonatal sepsis). Adjustment for possible confounders was performed by adding the variables described above to the models, in blocks of common variables (e.g. antenatal). Ordinal variables were tested for linearity and included in the model as linear terms if appropriate. In the second sensitivity analyses we investigated if the association between the SNPs and the risk of resuscitation was modified if the infant was at higher of risk of poor condition at birth (defined as:
breech deliveries, emergency caesarean sections, instrumental deliveries, low birth weight (<10 th centile for gestational age), maternal hypertension).(27) In the third analysis we repeated the analysis including all SNPs in a single model, while in the fourth we investigated if any association was modified by the infants' gender.
All analyses were conducted with Stata 10 software (Stata Corp, TX, USA). All data are presented as odds ratio (OR) (95% confidence interval (CI)), mean (SD), mean difference (95% CI), median (interquartile range (IQR)), or number (percent).
RESULTS
There was no evidence that the SNPs measured were not in Hardy-Weinberg equilibrium, nor was there any evidence that any of the SNPs were in linkage disequilibrium with each other (all comparisons; p>0.10). In the univariable analysis, there was no evidence that rs2284411 or rs2498804 were associated with need for resuscitation, time to a normal Apgar score or development of hypoxic-ischemic encephalopathy (Table 3) . However, for rs1835740 the need for resuscitation (p=0.041) and the time to achieve a normal Apgar score (p=0.020) differed by genotype (Table 3) . Infants homozygous for the minor allele compared to wild-type were more likely to need resuscitation (9.2% vs. 7.0%) and took longer to achieve an Apgar score of 7-10 (number with low Apgar score beyond 5 minutes; 1.2% vs. 0.7%). There was no clear evidence that rs1835740 was associated with the risk of hypoxic-ischaemic encephalopathy.
In the logistic regression neither rs2284411or rs2498804 were found to be associated with the need for resuscitation, time to a normal Apgar score or hypoxic-ischaemic encephalopathy (Table   4 In the sensitivity analysis, adjusting for antenatal or intrapartum factors did not substantially modify any relationship seen in the initial model, with no association between 2 of the SNPs (rs2284411, rs2498804) and the need for resuscitation ( Table 5 ). The association between rs1835740 and resuscitation remained in both the model correcting for antenatal factors (OR 1.17 (1.01-1.35)) and antenatal/intrapartum factors (OR 1.18 (1.00-1.38)). There was no evidence that high risk delivery modified the relationship between any of these SNPs and the need for resuscitation (rs2284411, p=0.657; rs2498804, p=0.958; rs1835740, p=0.401). Using a model with all 3 SNPs in showed no substantial difference from the main analysis, with only evidence that rs1835740 was associated with the need for resuscitation (OR 1.17 (1.01 to 1.35)), while there was no evidence that gender modified any association between the SNPs and the need for resuscitation (all p values greater than 0.5).
DISCUSSION
In this cohort one of the SNPs, rs1835740, implicated in glutamate homeostasis and signalling
showed an association with birth condition in both the need for resuscitation and the length of time the infant took to achieve a normal Apgar score (Table 3 ). This is, to our knowledge, the first time a functional SNP in the excitatory neurotransmitter pathway has been associated with this important perinatal outcome.
Similarly to the majority of SNPs that have been found to be associated with human complex diseases and traits in genome-wide association studies, rs1835740 is located between two genes (AEG1 and PGCP). AEG1 and PGCP are involved in glutamate homeostasis (22) . Genome-wide expression quantitative trait locus (eQTL) analysis in lymphoblastoid cells has indicated that s1835740 is a cis-acting regulator of the former gene (22) and the risk allele A is associated with higher expression levels of AEG-1. Furthermore, it has been shown that AEG-1 downregulates the expression of the glutamate transporter EAAT2 in cultured astrocytes (30) . Taking all these together, in infants with the A allele the expression level of AEG-1 is likely to be elevated which in turn can downregulate EAAT-2 resulting in pathological extracellular glutamate levels and increased susceptibility to hypoxia-ischaemiainduced excitotoxicity. (22) While the underlying pathological mechanisms are not fully understood, it is plausible that the rs1835740 SNP modifies the impact of otherwise physiological levels of hypoxia to produce cerebral glutamate concentrations substantial enough to produce clinical depression at birth. have investigated were all measured directly on the infants we were not able to get data on those infants who fell outside the standardising procedure used in the genotyping and so were not able to investigate the effect of ethnicity due to the low levels of variance in the population. Given the lack of dependencies between the SNPs, adjustment for multiple testing in this a-priori work would be over-conservative. Bonferroni correction would propose that a 'significant' p-values cut-off of <0.017 could be used (instead of 0.05). None of our analyses obtained this level of evidence, and this emphases that the association seen in this work may simply be that of chance (false positive error) and further work to confirm or refute this is needed. We need to acknowledge that we have not adjusted the p-values for multiple testing, as all three SNPs were defined a-priori and are not in linkage disequilibrium with each other. Two of the three SNPs (rs2284411 and rs2498804) did not show significant association with birth condition, and thus it is likely that they play no role in the physiological cascade around birth, or that any functional effect they might have is not measurable in this work. However the confidence intervals (for resuscitation and Apgar scores at least) were relatively narrow suggesting we are likely to be missing only a small effect of these two other SNPs, should one exist. However due to the imprecision in the point estimates it is important not to see this work as evidence of no association. Of note, results were identical when the analysis was repeated excluding infants born at 36 weeks.
This work shows that genetic variation has measurable and potentially important impact on perinatal health and the birth process itself, which in turn is associated with poorer cognitive skills, psychiatric morbidity and worse pragmatic, social outcomes. (1,2,7) We also know that interventions around the birth process can modify this risk, with recent work suggesting risk profiling may be of use. (29) Of interest, none of the three SNPs investigated here were associated with a higher risk of an emergency LSCS (all p-values >0.5). Non-invasive fetal genotyping is also becoming possible with recent technical advances giving the possibility of incorporating important
SNPs into a risk prediction strategy to reduce perinatal asphyxia by targeted obstetric intervention.
We have tested 3 candidate SNPs to measure any association with birth condition, and while there was no significant association between the SNPs in the GluN2B and Akt1 genes with birth condition there was evidence that the rs1835740 was associated with the need for resuscitation and Apgar scores, with an imporant population impact. This association was not confounded by antenatal or intrapartum factors in a sensitivity analysis. 
Birth condition
Resuscitated 529 (7.5%) Apgar score at 1 min 9 (8-9) Apgar score at 5 min 10 (9-10) Numbers are n(%), median (IQR) or mean (SD) as appropriate 
